LPS treatment is used to stimulate sterile inflammation in culture (Frost et al., 2002) by acting on Toll Like Receptor 4 (TLR4), a cellular membrane sensor of damage and infection that also triggers the caspase-11 non-canonical inflammasome (Yang et al., 2015; Cieslelska et al., 2021). This evidence concerns the gene TLR4 and infection.